521286-38-4,
rac-Boc Norvaline,
2-{[(tert-butoxy)carbonyl]amino}pentanoic acid,
2-tert-Butoxycarbonylamino-pentanoic acid,
2-([(TERT-BUTOXY)CARBONYL]AMINO)PENTANOIC ACID,
Norvaline, N-[(1,1-dimethylethoxy)carbonyl]-,
2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid,
Boc-DL-norvaline,
NSC343953,
N-Boc-aminovaleric acid,
AC1Q2UMO,
AC1L70HV,
2-(Boc-amino)pentanoic Acid,
N-alpha-t-BOC-L-NORVALINE,
NOR004,
SCHEMBL1231627,
CTK9A0264,
DTXSID20307083,
t-butoxycarbonylamino valeric acid,
INWOAUUPYIXDHN-UHFFFAOYSA-N,
ALBB-028279,
NSC186911,
AKOS009157797,
MCULE-5715842421,
NE11439,
NSC-186911,
NSC-343953,
2-tert-Butoxycarbonylaminopentanoic Acid,
AK-49864,
AK-49939,
SY017991,
N-[(1,1-Dimethylethoxy)carbonyl]norvaline,
2-[(tert-butoxycarbonyl)amino]pentanoic acid,
FT-0663546,
EN300-62478,
MFCD00037268 (98%),
Norvaline,N-[(1,1-dimethylethoxy)carbonyl]-(9CI),
Z1259161839,
Boc-Nva-OH,
Boc-L-norvaline,
CID302433,
(R)-2-((tert-Butoxycarbonyl)amino)pentanoic acid,
53308-95-5,
Norvaline, N-[(1,1-dimethylethoxy)carbonyl]- (9CI),
57521-85-4,